Maternal and fetal adropin levels in gestational diabetes mellitus

Basit Öğe Kaydı
dc.authoridMinareci, Yagmur/0000-0003-1420-9318
dc.authoridKaraer, Abdullah/0000-0002-2010-6211
dc.authoridCelik, ebru/0000-0002-0774-4294
dc.authoridTURKCUOGLU, ILGIN/0000-0002-8342-1956
dc.authorwosidUlas, mustafa/KIE-9518-2024
dc.authorwosidSimsek, Yavuz/AAH-9894-2021
dc.authorwosidMinareci, Yagmur/AAJ-7114-2021
dc.authorwosidKaraer, Abdullah/ABI-4667-2020
dc.authorwosidCelik, ebru/X-4343-2019
dc.contributor.authorCelik, Ebru
dc.contributor.authorYilmaz, Ercan
dc.contributor.authorCelik, Onder
dc.contributor.authorUlas, Mustafa
dc.contributor.authorTurkcuoglu, Ilgin
dc.contributor.authorKaraer, Abdullah
dc.contributor.authorSimsek, Yavuz
dc.date.accessioned2024-08-04T20:37:42Z
dc.date.available2024-08-04T20:37:42Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: To evaluate maternal and cord blood serum adropin concentrations in pregnant women with gestational diabetes mellitus (GDM). Study design: Twenty pregnant women with GDM and 20 gestational age-matched healthy pregnant women participated in the study. Maternal serum and cord blood adropin levels were assessed using an enzyme immunosorbent assay, at the time of birth. The relation of maternal serum and cord blood adropin levels with metabolic parameters were also assessed. Results: The mean maternal and cord serum adropin in the GDM group were significantly lower than those of the control women (P = 0.01 and P<0.001, respectively). Maternal serum adropin levels did not correlate with either fetal serum adropin levels or maternal metabolic values. Conclusion: The data suggest that low adropin levels may contribute to the underlying pathogenesis of GDM.en_US
dc.identifier.doi10.1515/jpm-2012-0227
dc.identifier.endpage380en_US
dc.identifier.issn0300-5577
dc.identifier.issn1619-3997
dc.identifier.issue4en_US
dc.identifier.pmid23314506en_US
dc.identifier.scopus2-s2.0-84879800509en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage375en_US
dc.identifier.urihttps://doi.org/10.1515/jpm-2012-0227
dc.identifier.urihttps://hdl.handle.net/11616/96123
dc.identifier.volume41en_US
dc.identifier.wosWOS:000321288000005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWalter De Gruyter Gmbhen_US
dc.relation.ispartofJournal of Perinatal Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdropinen_US
dc.subjectcord blooden_US
dc.subjectgestational diabetes mellitusen_US
dc.subjectglucoseen_US
dc.subjecthomeostasis model of assessment - insulin resistance (HOMA-IR)en_US
dc.titleMaternal and fetal adropin levels in gestational diabetes mellitusen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu